Release Date: 27/10/20 08:17 Summary: Quarterly Activities & Cashflow Report Price Sensitive: Yes Download Document 1.98MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%